Comprehensive Guide to Fibrin Sealant (Tisseel) in Orthopedic Surgery

In the rapidly evolving landscape of orthopedic surgery, the need for advanced hemostatic agents and tissue adhesives has never been more critical. Fibrin sealant, most notably known by the brand name Tisseel, represents a gold-standard approach to managing surgical bleeding and facilitating tissue approximation. Unlike traditional sutures or staples, which can cause mechanical trauma to delicate structures, Tisseel acts as a biological bridge, mimicking the final stages of the natural coagulation cascade.

This guide provides an exhaustive look into the clinical utility, biomechanical properties, and procedural application of Fibrin Sealant (Tisseel) within orthopedic practice.

Technical Specifications and Mechanisms of Action

Tisseel is a two-component fibrin sealant that mimics the human body’s physiological blood clotting process. It is composed of a Sealer Protein Concentrate (human) and Thrombin (human). When these two components are mixed, they form a stable, elastic, and biodegradable fibrin clot.

The Biochemical Cascade

The mechanism of action follows the final pathway of the coagulation cascade:
1. Activation: Thrombin converts fibrinogen into fibrin monomers.
2. Polymerization: These monomers undergo polymerization to form a fibrin network.
3. Stabilization: Factor XIII, present in the concentrate, cross-links the fibrin network, enhancing its mechanical strength and resistance to fibrinolysis.

Key Biomechanical Properties

Extensive Clinical Indications and Usage

In orthopedics, Tisseel is utilized far beyond simple hemostasis. It is a multifunctional tool that improves surgical efficiency and patient recovery.

Common Orthopedic Applications

• Total Joint Arthroplasty (TJA): Used to reduce postoperative drainage and hematoma formation in total hip and knee replacements.
• Rotator Cuff Repair: Applied to the bone-tendon interface to enhance biological integration and decrease the rate of re-tear.
• Spinal Surgery: Utilized in dural repairs to prevent cerebrospinal fluid (CSF) leaks.
• Bone Grafting: Acts as a scaffold to hold bone graft particles (autograft or allograft) in place, promoting osteoconductivity.
• Fracture Fixation: Assists in stabilizing small bone fragments where traditional hardware may be impractical.

Procedural Fitting and Application

Tisseel is typically delivered via a dual-chamber syringe system. The "Duploject" or similar applicator ensures that the two components mix only at the point of application.

1. Preparation: The components must be thawed and warmed to 33–37°C before use.
2. Site Preparation: The target surgical site must be cleaned of excess blood or saline to ensure optimal adhesion.
3. Application: Apply a thin, even layer to the tissue surfaces.
4. Setting Time: The sealant usually achieves a firm set within 60 to 120 seconds. Surgeons should hold the tissue in the desired position during this period.

Maintenance and Sterilization Protocols

As a biological product, Fibrin Sealant requires strict adherence to cold chain management and handling protocols.

• Storage: Must be stored in a freezer at ≤ -20°C.
• Thawing: Thawing should occur in a controlled water bath or an incubator at 33–37°C. Avoid microwave thawing, as this will denature the proteins and render the sealant ineffective.
• Sterility: The product is sterile and for single-patient use only. Once thawed, it must be used within a specific timeframe (usually 4 to 24 hours depending on the storage temperature post-thaw).
• Disposal: Any unused material must be disposed of as biohazardous waste according to institutional protocols.

Patient Outcome Improvements

The integration of Tisseel into orthopedic protocols has shown measurable benefits in clinical literature:

1. Reduced Postoperative Drainage

By sealing open vascular channels in the bone marrow and soft tissue, Tisseel significantly reduces the volume of postoperative drainage. This often leads to a decreased need for surgical drains, which in turn lowers the risk of ascending infections.

2. Decreased Hematoma Formation

Hematomas are a known risk factor for surgical site infection (SSI) and prosthetic joint infection (PJI). By minimizing dead space, Tisseel limits the accumulation of blood, creating a more favorable environment for healing.

3. Accelerated Tissue Integration

In soft-tissue-to-bone repairs (like the rotator cuff), the fibrin scaffold encourages cellular infiltration and collagen deposition. This biological "glue" helps bridge the gap before permanent fibrocartilage union occurs.

Risks, Side Effects, and Contraindications

While Tisseel is highly effective, it is not without risks. Clinical judgment is required for every patient.

• Hypersensitivity: As a human-derived product, there is a remote risk of allergic reactions (anaphylaxis).
• Intravascular Injection: Must never be injected into blood vessels, as it can cause systemic thromboembolic events.
• Infection Risk: While the product is virus-inactivated, it is a biological material and should not be used in the presence of active, uncontrolled infections.
• Contraindications: Do not use in patients with known hypersensitivity to bovine or human proteins.

Massive FAQ Section

1. What is the primary difference between Tisseel and surgical glue?

Tisseel is a fibrin-based biological sealant, whereas many "surgical glues" (like cyanoacrylates) are synthetic polymers. Tisseel is biodegradable and biocompatible, while synthetics are often permanent and can cause inflammatory foreign-body reactions.

2. Can Tisseel be used on infected wounds?

No. Tisseel should not be applied to infected or contaminated surgical sites, as it may trap bacteria within the fibrin clot.

3. Does Fibrin Sealant replace sutures?

It is intended as an adjunct to standard surgical techniques. It should be used to supplement sutures or staples, not replace them in high-tension areas.

4. How long does it take for Tisseel to be absorbed by the body?

The rate of resorption depends on the site of application and the patient’s local fibrinolytic activity, typically ranging from a few days to several weeks.

5. Is Tisseel safe for use in pediatric orthopedics?

Yes, it is used in pediatric surgery, but dosing and application must be carefully managed by the surgical team to avoid over-application.

6. What happens if Tisseel is applied too thickly?

Excessive application can lead to a delayed inflammatory response or a physical barrier that prevents proper tissue-to-tissue contact. A thin, uniform layer is always preferred.

7. Can Tisseel be used with bone grafts?

Yes, it is frequently used to create a "paste" with bone graft material, making it easier to pack into defects.

8. Are there any blood-borne pathogen risks?

Tisseel is produced from human plasma that undergoes rigorous viral inactivation and screening processes, making the risk of pathogen transmission extremely low.

9. How do I know if the sealant has expired?

Always check the expiration date on the packaging. Once thawed, the product has a limited shelf life, which is clearly defined in the package insert.

10. Can Tisseel be used in minimally invasive surgery (MIS)?

Yes, its application system is well-suited for MIS, as it can be delivered through long, thin applicators to reach deep, confined spaces.

Conclusion

Fibrin Sealant (Tisseel) is a sophisticated, versatile tool that has become indispensable in modern orthopedic surgery. By understanding its biochemical mechanisms, adhering to strict preparation protocols, and applying it judiciously, surgeons can significantly improve patient outcomes—reducing the incidence of hematomas, decreasing blood loss, and fostering better tissue integration. As orthopedics continues to move toward more biological and less invasive solutions, the role of fibrin sealants will only continue to grow, solidifying its place as a cornerstone of advanced surgical care.